Abstract
Mitocans are a group of drugs known to target the mitochondria of cancer cells. Mitochondria being an unusual double membraneand highly negative potential may challenge the efficient delivery of mitocans. To overcome such challenges, the nanotechnology-based drug delivery system is considered to be efficient and highly explored. Our study aims to explore the potential of selected nanocarriers i.e. carbon nanotubes (CNT) and fullerenes (C60 and C70) to selectively deliver mitocans to the enzyme hexokinase-2 (HK2). Our in-silico analysis suggests that CNT can be used as potential nanocarriers for the selective delivery of the mitocans to HK2.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
